Picture of XBiotech logo

XBIT — XBiotech News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMicro CapNeutral

Brief: XBiotech Inc Plans To Seek FDA Guidance Based On Phase III Studies In Oncology Findings

Oct 31 (Reuters) - XBiotech Inc  XBIT.O :
    * XBIOTECH INC - PLANS TO SEEK FDA GUIDANCE BASED ON PHASE
III
STUDIES IN ONCOLOGY FINDINGS
    * XBIOTECH - INCREASING OUTPUT CAPACITY FOR SYRINGES WITH
TARGET
ANNUAL PRODUCTION CAPACITY OF ABOUT 300,000 UNITS BY 2019

Source text for Eikon:  ID:nGNX5tldgD 
Further company coverage:  XBIT.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on XBiotech

See all news